 Matrix Metalloproteinase 1
"Matrix Metalloproteinase 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the metalloproteinase family of enzymes that is principally responsible for cleaving FIBRILLAR COLLAGEN. It can degrade interstitial collagens, types I, II and III.
| Descriptor ID |
D020781
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.351 D08.811.277.656.300.480.525.700.100 D08.811.277.656.675.374.205.351 D08.811.277.656.675.374.525.700.100 D12.644.276.848.100 D12.776.467.836.100
|
| Concept/Terms |
Matrix Metalloproteinase 1- Matrix Metalloproteinase 1
- Metalloproteinase 1, Matrix
- Interstitial Collagenase
- MMP1 Metalloproteinase
- Metalloproteinase, MMP1
- MMP-1 Metalloproteinase
- MMP 1 Metalloproteinase
- Metalloproteinase, MMP-1
- Matrix Metalloproteinase-1
Pro-Matrix Metalloproteinase-1- Pro-Matrix Metalloproteinase-1
- Metalloproteinase-1, Pro-Matrix
- Pro Matrix Metalloproteinase 1
- Promatrixmetalloproteinase-1
- Promatrixmetalloproteinase 1
- proMMP-1
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 1".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 1".
This graph shows the total number of publications written about "Matrix Metalloproteinase 1" by people in this website by year, and whether "Matrix Metalloproteinase 1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 2 | 0 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 2 | 0 | 2 | | 2013 | 0 | 2 | 2 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 1 | 2 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Matrix Metalloproteinase 1" by people in Profiles.
-
Kahn D, Macias E, Zarini S, Garfield A, Zemski Berry K, MacLean P, Gerszten RE, Libby A, Solt C, Schoen J, Bergman BC. Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease. Endocrinology. 2022 10 11; 163(11).
-
Blatchley MR, Hall F, Wang S, Pruitt HC, Gerecht S. Hypoxia and matrix viscoelasticity sequentially regulate endothelial progenitor cluster-based vasculogenesis. Sci Adv. 2019 03; 5(3):eaau7518.
-
Nagel MA, Choe A, Rempel A, Wyborny A, Stenmark K, Gilden D. Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts. J Neurol Sci. 2015 Nov 15; 358(1-2):444-6.
-
Zhao X, Fan J, Zhi F, Li A, Li C, Berger AE, Boorgula MP, Barkataki S, Courneya JP, Chen Y, Barnes KC, Cheadle C. Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. Hum Mol Genet. 2015 Aug 15; 24(16):4615-24.
-
Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Malvar Fernandez B, van Es IE, van Baarsen LG, Gay S, McKinsey TA, Tak PP, Baeten DL, Reedquist KA. Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression. Ann Rheum Dis. 2016 Feb; 75(2):430-8.
-
Heinhuis B, Popa CD, van Tits BL, Kim SH, Zeeuwen PL, van den Berg WB, van der Meer JW, van der Vliet JA, Stalenhoef AF, Dinarello CA, Netea MG, Joosten LA. Towards a role of interleukin-32 in atherosclerosis. Cytokine. 2013 Oct; 64(1):433-40.
-
Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One. 2013; 8(5):e63165.
-
Cornish TC, Bagnasco SM, Macgregor AM, Lu J, Selvin E, Halushka MK. Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects. J Histochem Cytochem. 2009 Nov; 57(11):995-1001.
-
Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, Russell AJ. Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater. 2008 Sep; 4(5):1411-20.
-
Wang H, Ogawa M, Wood JR, Bartolomei MS, Sammel MD, Kusanovic JP, Walsh SW, Romero R, Strauss JF. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet. 2008 Apr 15; 17(8):1087-96.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|